Management of Barrett's esophagus in the UK: Overtreated and underbiopsied but improved by the introduction of a national randomized trial

American Journal of Gastroenterology

Volumn 103, Issue 5, 2008, Pages 1079-1089

  Das, Debasish ^a   Ishaq, Savid ^a   Harrison, Rebecca ^a   Kosuri, Kiran ^a   Harper, Edward ^b   DeCaestecker, John ^a   Sampliner, Richard ^c   Attwood, Stephen ^d   Barr, Hugh ^e   Watson, Peter ^f   Moayyedi, Paul ^g   Jankowski, Janusz ^a,h  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^e GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^g MCMASTER UNIVERSITY   (Canada)

^h UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CLINICAL PRACTICE; DYSPLASIA; ESOPHAGUS BIOPSY; EVIDENCE BASED MEDICINE; HISTOPATHOLOGY; HUMAN; MEDICAL PRACTICE; MEDICAL SPECIALIST; NORMAL HUMAN; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BIOPSY; DATA COLLECTION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; GREAT BRITAIN; GUIDELINE ADHERENCE; HUMANS; MASS SCREENING; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRECANCEROUS CONDITIONS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; STATE MEDICINE; SURVIVAL RATE; UNNECESSARY PROCEDURES;

EID: 43549110733     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01790.x     Document Type: Article

References (33)

1. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991 265 : 1287 9.
2. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990 62 : 440 3.
3. JanKowski JA, Harrison RF, Perry I, et al. Barrett's metaplasia. Lancet 2000 356 : 2079 85.
4. Ferguson MK, Durkin A. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg 2002 6 : 29 35.
5. Incarbone R, Bonavina L, Saino G, et al. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus. Surg Endosc 2002 16 : 263 6.
6. Inadomi JM, Sampliner R, Lagergren J, et al. Screening and surveillance for Barrett esophagus in high-risk groups: A cost-utility analysis. Ann Intern Med 2003 138 : 176 86.
7. Sonnenberg A, Soni A, Sampliner RE. Medical decision analysis of endoscopic surveillance of Barrett's oesophagus to prevent oesophageal adenocarcinoma. Aliment Pharmacol Ther 2002 16 : 41 50.
8. Jankowski JA, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology 2002 122 : 588 90.
9. Sampliner RE. Practice Parameters Committee of ACG. Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2002 97 : 1888 95.
10. Watson A, Heading RC, Shepherd NA for the Working Party of the British Society of Gastorenterology. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus. Available at : http://www.bsg.org.uk/ bsgdisp1.php?id=3f4a76385e42599499e9&h=1&sh=1&i=1&b=1&m= 00023. Accessed January 15, 2008.
11. Mandal A, Playford R, Wicks AC. Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK. Aliment Pharmacol Ther 2003 17 : 1319 24.
12. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus - the Prague C and M criteria. Gastroenterology 2006 131 : 1392 9.
13. Ackroyd R, Wakefield SE, Williams JL, et al. Surveillance of Barrett's esophagus: A need for guidelines? Dis Esophagus 1997 10 : 185 9.
14. Falk GW, Ours TM, Richter JE. Practice patterns for surveillance of Barrett's esophagus in the United States. Gastrointest Endosc 2000 52 : 197 203.
15. Gross CP, Canto MI, Hixson J, et al. Management of Barrett's esophagus: A national study of practice patterns and their cost implications. Am J Gastroenterol 1999 94 : 3440 7.
16. Smith AM, Maxwell-Armstrong CA, Welch NT, et al. Surveillance for Barrett's oesophagus in the UK. Br J Surg 1999 86 : 276 80.
17. van Sandick JW, Bartelsman JF, van Lanschot JJ, et al. Surveillance of Barrett's oesophagus: Physicians' practices and review of current guidelines. Eur J Gastroenterol Hepatol 2000 12 : 111 7.
18. Abdalla AA, Petersen BT, Ott BJ, et al. Impact of feedback and didactic sessions on the reporting behavior of upper endoscopic findings by physicians and nurses. Clin Gastroenterol Hepatol 2007 5 : 326 30.
19. Vakil N, van Zanten SV, Kahrilas P, et al. Global Consensys group. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol 2006 101 : 1900 20.
20. Harrison R, Perry I, Haddadin W, et al. Barrett's oesophagus: Value of detailed examination over endoscopic diagnosis. Am J Gastroenterol 2007 102 : 1154 61.
21. Falk GW. Barrett's esophagus. Gastroenterology 2002 122 : 1569 91.
22. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation. Hum Pathol 2001 32 : 368 78.
23. Ormsby AH, Petras RE, Henricks WH, et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002 51 : 671 6.
24. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001 120 : 1607 19.
25. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003 349 : 2117 27.
26. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990 99 : 918 22.
27. Macdonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of undergoing surveillance for Barrett's oesophagus: Observational study. BMJ 2000 321 : 1252 5.
28. Dulai GS, Guha S, Kahn KL, et al. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review. Gastroenterology 2002 122 : 26 33.
29. Corley DA, Levin TR, Habel LA, et al. Surveillance and survival in Barrett's adenocarcinomas: A population-based study. Gastroenterology 2002 122 : 633 40.
30. Bampton PA, Schloithe A, Bull J, et al. Improving surveillance for Barrett's oesophagus. BMJ 2006 332 : 1320 3.
31. Corley DA, Kerlikowske K, Verma R, et al. Protective association of aspirin/NSAID and esophageal cancer; a systematic review and meta-analysis. Gastroenterology 2003 124 : 47 56.
32. Jankowski JA, Moayyedi P. Aspirin as chemoprevention for Barrett's esophagus: A large RCT underway in the UK. J Natl Cancer Inst 2004 96 : 885 7.
33. Jankowski J, Barr H. Improving surveillance for Barrett's oesophaqus; AspECT and BOSS trials provide an evidence base. BMJ 2006 332 : 1512.